154 related articles for article (PubMed ID: 3033616)
1. High affinity binding of cholecystokinin to small cell lung cancer cells.
Yoder DG; Moody TW
Peptides; 1987; 8(1):103-7. PubMed ID: 3033616
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
3. Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors.
Huang SC; Yu DH; Wank SA; Mantey S; Gardner JD; Jensen RT
Peptides; 1989; 10(4):785-9. PubMed ID: 2479932
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain.
Cross AJ; Slater P; Skan W
Neuropeptides; 1988; 11(2):73-6. PubMed ID: 3368039
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi JC; Schaer JC; Waser B
Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
[TBL] [Abstract][Full Text] [Related]
7. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
8. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
Schäfer U; Harhammer R; Boomgaarden M; Sohr R; Ott T; Henklein P; Repke H
J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271
[TBL] [Abstract][Full Text] [Related]
9. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels.
Jansen JB; Lamers CB
J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a new labeled gastrin ligand, 125-I-BH-[Leu15]-gastrin-(5-17), on binding to canine fundic mucosal cells and Jurkat cells.
Galleyrand JC; Lima-Leite AC; Lallement JC; Lignon MF; Bernad N; Fulcrand P; Martinez J
Int J Pept Protein Res; 1994 Oct; 44(4):348-56. PubMed ID: 7875937
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
12. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
Staley J; Jensen RT; Moody TW
Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
[TBL] [Abstract][Full Text] [Related]
13. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin.
Silvente-Poirot S; Wank SA
J Biol Chem; 1996 Jun; 271(25):14698-706. PubMed ID: 8663021
[TBL] [Abstract][Full Text] [Related]
14. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
16. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
Lallement JC; Oiry C; Lima-Leite AC; Lignon MF; Fulcrand P; Galleyrand JC; Martinez J
Eur J Pharmacol; 1995 Jul; 290(2):61-7. PubMed ID: 8575534
[TBL] [Abstract][Full Text] [Related]
18. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
Lallement JC; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1994 May; 267(3):297-305. PubMed ID: 8088368
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
Lin CW; Miller T
J Pharmacol Exp Ther; 1985 Mar; 232(3):775-80. PubMed ID: 2983069
[TBL] [Abstract][Full Text] [Related]
20. A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK 8 and CCK 4 cholecystokinin receptor binding site.
Clark CR; Daum P; Hughes J
J Neurochem; 1986 Apr; 46(4):1094-101. PubMed ID: 3005503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
